Renal Dysfunction in Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial

BACKGROUND: Patients with heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD) represent a high-risk phenotype. The Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction (RELAX) trial enrol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Card Fail
Autors principals: Patel, Ravi B., Mehta, Rupal, Redfield, Margaret M., Borlaug, Barry A., Hernandez, Adrian F., Shah, Sanjiv J., Dubin, Ruth F.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078015/
https://ncbi.nlm.nih.gov/pubmed/31931098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2020.01.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars